TREM2 INHIBITION REPROGRAMS MYELOID CELLS TO STIMULATE ANTI-TUMOR IMMUNITY THROUGH BOTH DIRECT AND INDIRECT MECHANISMS

被引:0
|
作者
Sun, Rui [1 ]
Han, Rowland [1 ]
McCornack, Colin [1 ]
Tabor, G. Travis [1 ]
Hou, Jinchao [1 ]
Cleary, Ryan [1 ]
Mao, Diane [1 ]
Liu, Qin [1 ]
Schoch, Kathleen [1 ]
Luo, Jingqin [1 ]
Petti, Allegra [2 ]
Miller, TImothy [1 ]
Ulrich, Jason [1 ]
Holtzman, David [1 ]
Kim, Albert [1 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Mass Gen Hosp, Boston, MA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IMMU-28
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Modulation of Nr2f2 reprograms tumor blood vessels to enhance anti-tumor immunity and immunotherapy.
    Zhu, Yu
    Lazarus, Nicole
    Brulois, Kevin
    Salazar, Nicole
    Dinh, Theresa
    Pan, Junliang
    Butcher, Eugene
    CANCER RESEARCH, 2021, 81 (13)
  • [22] Nanomedicine Targeting Myeloid-Derived Suppressor Cells Enhances Anti-Tumor Immunity
    Yang, En-Li
    Sun, Zhi-Jun
    ADVANCED HEALTHCARE MATERIALS, 2024, 13 (09)
  • [23] TREM2, a critical activator of pyroptosis, mediates the anti-tumor effects of piceatannol in uveal melanoma cells via caspase 3/GSDME pathway
    Jiu, Xudong
    Li, Wenjie
    Liu, Yang
    Liu, Lin
    Lu, Hong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2024, 54 (05)
  • [24] Therapeutic targeting of TREM1 with PY159 promotes myeloid cell reprogramming and unleashes anti-tumor immunity
    Mayes, Erin
    Juric, Vladi
    Binnewies, Mikhail
    Canaday, Pamela
    Lee, Tian
    Dash, Subhadra
    Pollack, Joshua L.
    Rudolph, Joshua
    Huang, Vicky
    Du, Xiaoyan
    Jahchan, Nadine
    Ramoth, Asa J.
    Mankikar, Shilpa
    Norng, Manith
    Santamaria, Carlos
    Baker, Kevin P.
    Liang, Linda
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [25] Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
    Andre, Pascale
    Denis, Caroline
    Soulas, Caroline
    Bourbon-Caillet, Clarisse
    Lopez, Julie
    Arnoux, Thomas
    Blery, Mathieu
    Bonnafous, Cecile
    Gauthier, Laurent
    Morel, Ariane
    Rossi, Benjamin
    Remark, Romain
    Breso, Violette
    Bonnet, Elodie
    Habif, Guillaume
    Guia, Sophie
    Lalanne, Ana Ines
    Hoffmann, Caroline
    Lantz, Olivier
    Fayette, Jerome
    Boyer-Chammard, Agnes
    Zerbib, Robert
    Dodion, Pierre
    Ghadially, Hormas
    Jure-Kunkel, Maria
    Morel, Yannis
    Herbst, Ronald
    Narni-Mancinelli, Emilie
    Cohen, Roger B.
    Vivier, Eric
    CELL, 2018, 175 (07) : 1731 - +
  • [26] FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity
    Mysore, Vijayashree
    Cullere, Xavier
    Mears, Joseph
    Rosetti, Florencia
    Okubo, Koshu
    Liew, Pei X.
    Zhang, Fan
    Madera-Salcedo, Iris
    Rosenbauer, Frank
    Stone, Richard M.
    Aster, Jon C.
    von Andrian, Ulrich H.
    Lichtman, Andrew H.
    Raychaudhuri, Soumya
    Mayadas, Tanya N.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [27] Targeting Granulocytic Myeloid Derived Suppressor Cells Promotes Anti-Tumor Immunity in Pancreas Adenocarcinoma
    Nywening, T.
    Belt, B.
    Fields, R. C.
    Hawkins, W.
    Denardo, D. G.
    Goedegebuure, P.
    Linehan, D. C.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S163 - S164
  • [28] Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
    David G. DeNardo
    Pauline Andreu
    Lisa M. Coussens
    Cancer and Metastasis Reviews, 2010, 29 : 309 - 316
  • [29] Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
    DeNardo, David G.
    Andreu, Pauline
    Coussens, Lisa M.
    CANCER AND METASTASIS REVIEWS, 2010, 29 (02) : 309 - 316
  • [30] Unfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancer
    Cubillos-Ruiz, Juan R.
    Mohamed, Eslam
    Rodriguez, Paulo C.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5